Format

Send to

Choose Destination
Am J Surg. 2015 Jun;209(6):1013-9. doi: 10.1016/j.amjsurg.2014.06.027. Epub 2014 Aug 7.

Survival in anaplastic thyroid cancer in relation to pre-existing goiter: a population-based study.

Author information

1
Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands.
2
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Research, Comprehensive Cancer Centre The Netherlands, Utrecht, The Netherlands.
3
Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
4
Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands. Electronic address: j.t.m.plukker@umcg.nl.

Abstract

BACKGROUND:

We investigated whether pre-existent goiter and well-differentiated thyroid cancer (WDTC) are associated with survival in anaplastic thyroid carcinoma (ATC).

METHODS:

We analyzed medical records from 94 ATC patients, drawn from the Netherlands Cancer Registry, diagnosed in 17 hospitals between 1989 and 2009.

RESULTS:

The 29 patients (31%) with pre-existent goiter, including 8 with WDTC, were younger than those without (median, 69 vs. 76 years; P = .02). One-year overall survival was 9% (95% confidence interval [CI], 3% to 14%) with no difference between pre-existent goiter or not (overall survival, 14%; 95% CI, 1% to 26% vs overall survival, 6%; 95% CI, 0% to 13%]). Higher age was associated with a worse survival (hazard rate, 1.03; 95% CI, 1.01 to 1.06]), whereas the hazard to die was lower after surgery and/or radiotherapy (hazard rate, .37; 95% CI, .21 to .67 and hazard rate, .22; 95% CI, .12 to .41, respectively).

CONCLUSIONS:

ATC patients with pre-existent goiter were younger, yet survival was not significantly different between those with or without pre-existent goiter or WDTC.

KEYWORDS:

Anaplastic thyroid carcinoma; Goiter; Survival

PMID:
25242682
DOI:
10.1016/j.amjsurg.2014.06.027
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center